SCHEMBL19836670

SCHEMBL19836670

C=C(C)c1cccc(CC)n1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.38
PARP1 P09874 1/20 0.37
BRD4 O60885 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
CYP1A2 P05177 1/20 0.36
IRAK4 Q9NWZ3 2/20 0.35
HRH4 Q9H3N8 1/20 0.34
CHRNB2 P17787 2/20 0.33
CHRNB4 P30926 2/20 0.33
CHRNA3 P32297 2/20 0.33
CHRNA4 P43681 2/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
CXCR4 P61073 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19085085 0.84 CCR1 (0.39) KCNH2BRD4NPSR1CYP1A2HRH4
SCHEMBL25885363 0.82 PARP1 (0.36) KCNH2PARP1BRD4NPSR1CYP1A2
SCHEMBL13793158 0.80 KDM4E (0.46) CYP1A2
SCHEMBL12432224 0.80 IRAK4 (0.49) KCNH2PARP1BRD4NPSR1CYP1A2
SCHEMBL22931529 0.78 IRAK4 (0.41) KCNH2PARP1BRD4NPSR1CYP1A2
SCHEMBL15102639 0.76 GRIN2D (0.44) KCNH2PARP1BRD4CYP1A2IRAK4
SCHEMBL979568 0.76 KDM4E (0.61) PARP1BRD4CYP1A2
SCHEMBL45869 0.75 KCNH2 (0.52) KCNH2PARP1NPSR1HRH4GRIN2D
Hydrochloric Acid SCHEMBL5239638 0.74 KDM4E (0.59) PARP1BRD4CYP1A2
SCHEMBL2829475 0.74 PARP1 (0.54) KCNH2PARP1BRD4NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021155321-A2 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2021-08-05 WO disclosed
WO-2020198537-A1 MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS ESCIENT PHARMACEUTICALS, INC. (US) 2020-10-01 WO disclosed
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP disclosed
EP-2944633-B1 PYRIDINE DERIVATIVE TEIJIN PHARMA LTD (JP) 2018-01-31 EP disclosed